- Home
- SPH vs ATRC Comparison
SPH vs ATRC Comparison
Compare SPH & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPH
- ATRC
- Stock Information
- Founded
- SPH 1945
- ATRC 2000
- Country
- SPH United States
- ATRC United States
- Employees
- SPH N/A
- ATRC N/A
- Industry
- SPH Other Specialty Stores
- ATRC Medical/Dental Instruments
- Sector
- SPH Consumer Discretionary
- ATRC Health Care
- Exchange
- SPH Nasdaq
- ATRC Nasdaq
- Market Cap
- SPH 1.1B
- ATRC 1.1B
- IPO Year
- SPH 1996
- ATRC 2005
- Fundamental
- Price
- SPH $19.74
- ATRC $38.47
- Analyst Decision
- SPH Hold
- ATRC Strong Buy
- Analyst Count
- SPH 3
- ATRC 9
- Target Price
- SPH $19.67
- ATRC $41.78
- AVG Volume (30 Days)
- SPH 171.1K
- ATRC 535.9K
- Earning Date
- SPH 02-06-2025
- ATRC 02-13-2025
- Dividend Yield
- SPH 6.59%
- ATRC N/A
- EPS Growth
- SPH N/A
- ATRC N/A
- EPS
- SPH 1.14
- ATRC N/A
- Revenue
- SPH $1,327,172,000.00
- ATRC $447,573,000.00
- Revenue This Year
- SPH N/A
- ATRC $17.75
- Revenue Next Year
- SPH $1.22
- ATRC $13.44
- P/E Ratio
- SPH $17.30
- ATRC N/A
- Revenue Growth
- SPH N/A
- ATRC 17.56
- 52 Week Low
- SPH $15.20
- ATRC $18.94
- 52 Week High
- SPH $21.55
- ATRC $39.12
- Technical
- Relative Strength Index (RSI)
- SPH 70.41
- ATRC 70.10
- Support Level
- SPH $17.40
- ATRC $31.00
- Resistance Level
- SPH $18.09
- ATRC $34.11
- Average True Range (ATR)
- SPH 0.48
- ATRC 1.76
- MACD
- SPH 0.28
- ATRC 0.86
- Stochastic Oscillator
- SPH 97.92
- ATRC 93.03
About SPH Suburban Propane Partners L.P.
Suburban Propane Partners LP distributes propane, fuel oil, and other refined fuels to customers in the East Coast and West Coast regions of the United States. Other operations include natural gas and electricity marketing in the deregulated New York and Pennsylvania markets. The company operates in three segments: Propane; Fuel Oil and Refined Fuels; and Natural Gas and Electricity. It generates maximum revenue from Propane segment.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.